Archive for the ‘CEPH’ Category:

Cash-Rich Companies Share the Wealth with Trillion-Dollar M&A Activity in 2011

{ Posted on Apr 18 2011 by Larry D. Spears }
No Comments
Tags :
Categories : AAPL, All, ARMH, CEPH, DUKE, EVR, HK, impact of mergers and acquisitions, Larry D. Spears, LZ, m&a activity, Mergers & Acquisitions, Mergers and Acquisitions, mergers and acquisitions valuation, MICC, Money, Money Morning, NSM, OXPS, PGN, PJC, recent mergers and acquisitions, SCHW, SEC, successful mergers and acquisitions, T, TXI, Uncategorized, VRX
Mergers and acquisitions, or M&A activity, so far in 2011 has been a driving force in the stock market's positive performance. In fact, global M&A activity in the first quarter topped $799.8 billion, the most since ...Read More »

Egypt’s Political Unrest Should Point Investors Toward U.S. Energy Producers and Crude Oil

{ Posted on Feb 07 2011 by Jon D. Markman }
No Comments
Categories : ABD, AGCO, AGL, AKAM, All, ALXN, AMAT, ATVI, AVP, AYE, BDX, BG, BMI, BRO, BWA, BWP, BZH, CCE, CEPH, COST, CSCO, CTSH, CUZ, CVH, DIS, DISCA, DLTR, DTE, DVA, EFX, ELNK, Energy, EPD, EXPE, FLIR, FLL, FMC, FRG, GBL, GCO, GDX, GDXJ, GRM, GS, GT, HAS, HUM, ICE, INTC, Investment News Briefs, IR, IT, Jon Markman, JWN, KFT, KIM, KO, LDSH, LNCR, LO, LPX, LUFK, MAC, MCD, MET, MLM, Money, Money Morning, NBL, NEM, NOV, NVDA, NVLS, Oil, OMC, PCH, PFG, PIKE, PRU, RL, ROST, S, SCU, SF, SHOO, SIAL, SLE, SON, SYY, TCLP, TDG, TIF, TQNT, UBS, Uncategorized, VECO, WBC, WFMI, WMG, WMGI, XOM, XRAY, XRT
Stocks lifted generously over the past week as investors celebrated the start of February with a bang amid cooling tempers in Egypt, guarded optimism in the halls of the U.S. Federal Reserve, stronger results among ...Read More »

Don’t Sleep Through Cephalon’s Growth

{ Posted on Jul 27 2010 by Ockham Research Staff }
No Comments
Categories : All, CEPH, Cephalon, Company Research, drugs, earnings, guidance, health care, Ockham, pharmaceuticals, upside surprise
Cephalon (CEPH) is a biopharmaceutical company that we have highlighted in the past, and they reported another outstanding quarter after the close on Tuesday.  The company’s most successful drug is Provigil, which is used to treat some sleep disorders, but ...Read More »